Porton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization

RegulatoryapprovedPositive

AI Analysis

Summary

Porton Advanced Solutions Ltd. has received a Drug Manufacturing License (Class C) from China's NMPA, enabling the company to expand its CDMO services to include commercialization manufacturing.

Outcome Details

Drug Manufacturing License (Class C) granted by NMPA

Importance:5/10

Sentiment:

0.70

CDMOmanufacturingChinaregulatory approvaldrug manufacturing license

Related Companies

$NHC $MDCE $CHHE

Read the original article

Published by PR Newswire Biotech on August 5, 2026 11:31 AM

Read Original